Integrated Patient Management System for the Improved Treatment of Asthma and Oth

用于改善哮喘及其他疾病治疗的综合患者管理系统

• 批准号: 8758747
• 负责人: Martin Culjat
• 金额: $ 22.5万
• 依托单位: FARUS, LLC
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-08-05 至 2015-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8758747
• 关键词: Accident and Emergency department; Accounting; Adherence; Asthma; Calibration; Caring; Chronic; Chronic Obstructive Airway Disease; Clinic; Clinical; Computer software; Cystic Fibrosis; Development; Diagnosis; Disease; Education; Electronics; Engineering; Ensure; Feedback; Fostering; General Practitioners; Guidelines; Healthcare Systems; Home environment; Impairment; Legal patent; Leisure Activities; Lung; Measurement; Measures; Molds; Outcome; Patients; Performance; Pharmaceutical Preparations; Phase; Physician Assistants; Physicians; Physicians' Offices; Pollen; Prevalence; Prevention program; Production; Pulmonary Function Test/Forced Expiratory Volume 1; Quality of life; Respiratory physiology; Risk; Rosa; Self Management; Severities; Small Business Innovation Research Grant; Solutions; Specialist; Spirometry; Symptoms; Syringes; System; Techniques; Technology; Telemetry; Temperature; Testing; Time; Transplantation; Treatment Step; Validation; Vision; Visit; Weather; Work; base; cost; design; effective therapy; experience; graphical user interface; improved; medical specialties; mobile application; new technology; novel; point of care; portability; pressure; prototype; public health relevance; respiratory; sensor; software development; tool; usability

DESCRIPTION (provided by applicant): Asthma is increasingly common and expensive. Current estimates place the number of people in the US with asthma at over 25M. Asthma accounts for one-quarter of all emergency room visits in the US. Direct treatment and indirect patient costs rose from $53B in 2002 to $56B in 2007 in the US. Globally, 300M people are estimated to have asthma with prevalence increasing 50% per decade and estimated costs over $100B per year. Proven effective treatments exist to control asthma but the disease is under-diagnosed, undertreated and adherence to medication is poor. Specialty care for asthma leads to improved outcomes and lower costs but there are too few asthma specialists to manage all asthmatics. Accurate assessment of asthma requires specific information about symptoms, medication use and objective lung function measurements (spirometry). Together these components provide the necessary information to evaluate asthma severity and asthma control as recommended by National Asthma Education and Prevention Program (NAEPP) guidelines, which describes these components as "impairment" and "risk". Accurate assessment of severity and control is critical to appropriate treatment choices from among the treatment steps articulated in the NAEPP guidelines. Under the current guidelines and best practices, asthma care management is primarily patient self- management based upon an asthma action plan provided by the physician. Specialists usually provide this but other physicians may not. As asthma specialists do not care for most asthmatics, other physicians and physician extenders need solutions to help them assess and manage asthma appropriately. At the same time, the influx of patients into the health care system under the Affordable Care Act necessitates a re-definition of point-of-care beyond the physician's office or clinic to include wherever the patient happens to be (home, work, leisure activities, etc.). Currently there is no mobile, affordable product that provides clinicians and patients with all the key components of asthma assessment and guides treatment choices enabling busy generalists and patients to follow clinical best practices are articulated in the guidelines. Our solution is a integrated system using novel technologies to provide both the non-specialist clinician and the patient with the tools to assess asthma accurately and guidance on developing an asthma action plan based on NAEPP guidelines. If successful, the paradigm will be expanded to other chronic respiratory conditions such as chronic obstructive pulmonary disease, cystic fibrosis and lung transplant.

描述(由申请者提供)：哮喘越来越常见，费用也越来越高。据目前的估计，美国哮喘患者的数量超过2500万。哮喘占美国所有急诊室就诊人数的四分之一。在美国，直接治疗和间接患者成本从2002年的530亿美元上升到2007年的560亿美元。据估计，全球有3亿人患有哮喘，患病率每十年增长50%，估计每年的成本超过1000亿美元。 已被证明有效的治疗方法可以控制哮喘，但这种疾病被低估了，治疗不足，对药物的依从性很差。对哮喘的专门护理可以改善结果并降低成本，但哮喘专家太少，无法管理所有哮喘患者。对哮喘的准确评估需要关于症状、用药和客观肺功能测量(肺活量测定法)的具体信息。根据国家哮喘教育和预防计划(NAEPP)指南的建议，这些组成部分一起提供必要的信息来评估哮喘严重程度和哮喘控制，该指南将这些组成部分描述为“损害”和“风险”。对严重程度和控制的准确评估对于从NAEPP指南中阐明的治疗步骤中进行适当的治疗选择至关重要。 在目前的指导方针和最佳实践下，哮喘护理管理主要是基于医生提供的哮喘行动计划的患者自我管理。专家通常会提供这一点，但其他医生可能不会。由于哮喘专家不照顾大多数哮喘患者，其他医生和医生推广人员需要解决方案来帮助他们适当地评估和管理哮喘。与此同时，根据《平价医疗法案》，患者大量涌入医疗保健系统，这就需要重新定义医生办公室或诊所以外的护理地点，将患者恰好在哪里(家庭、工作、休闲活动等)包括在内。 目前还没有一种移动的、负担得起的产品为临床医生和患者提供所有 指南阐明了哮喘评估和指南治疗选择的关键组成部分，使忙碌的全科医生和患者能够遵循临床最佳实践。我们的解决方案是一个使用新技术的集成系统，为非专科临床医生和患者提供准确评估哮喘的工具，并指导根据NAEPP指南制定哮喘行动计划。如果成功，该范例将扩展到其他慢性呼吸系统疾病，如慢性阻塞性肺疾病、囊性纤维化和肺移植。

项目成果

Integrated Self-Management System for Improved Treatment of Asthma

改善哮喘治疗的综合自我管理系统

• DOI: 10.3233/978-1-61499-625-5-262
• 发表时间: 2016
• 期刊: Studies in health technology and informatics
• 作者: Kristen T. Nguyen;M. Culjat;A. Mierzwa;Rahul S. Singh;B. Fong;R. Vanlandingham
• 通讯作者: R. Vanlandingham